Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories Ltd has informed BSE that its Board of Directors will meet on Tuesday, November 11, 2025, to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2025. This is a routine regulatory filing under SEBI's Listing Obligations and Disclosure Requirements, giving the stock exchange advance notice of the upcoming results announcement. The company has also confirmed that its insider trading window is closed from October 1, 2025 and will remain so until 48 hours after the results are formally declared. No financial figures or business commentary have been disclosed in this filing.
This is a standard procedural filing and has no direct impact on the stock price. Investors should watch for the actual Q2/H1 FY26 results on or after November 11, 2025 for any meaningful business update.